A major obstacle to the eradication of HIV-1 by combination antiretroviral therapy (cART) is the formation of cellular reservoirs in CD4 + T lymphocytes (carrying latently integrated provirus) and tissue macrophages. Infected macrophages assemble new virions in subcellular vacuoles known as virus containing compartments (VCC), hiding them from the immune system and, in part, from antiretroviral agents. We demonstrated that extracellular ATP is capable of inducing the rapid release of virions accumulated in VCC via interaction with the P2X7 receptor and without inducing cell death, whereas the antidepressant agent Imipramine blocks the release. Thus, our study identifies two "druggable" targets affecting the release of stored virions from infected human macrophages that could bear relevance for purging HIV-1 reservoirs in individuals receiving cART. HIV type 1 (HIV-1) infects CD4 + T lymphocytes and tissue macrophages. Infected macrophages differ from T cells in terms of decreased to absent cytopathicity and for active accumulation of new progeny HIV-1 virions in virus-containing compartments (VCC) (1-3). For these reasons, infected macrophages are believed to act as "Trojan horses" carrying infectious particles to be released on cell necrosis or functional stimulation (4). Here we explored the hypothesis that extracellular ATP (eATP) could represent a microenvironmental signal potentially affecting virion release from VCC of infected macrophages. Indeed, eATP triggered the rapid release of infectious HIV-1 from primary human monocyte-derived macrophages (MDM) acutely infected with the CCR5-dependent HIV-1 strain. A similar phenomenon was observed in chronically infected promonocytic U1 cells differentiated to macrophage-like cells (DU1) by costimulation with phorbol esters and urokinase-type plasminogen activator. Worthy of note, eATP did not cause necrotic, apoptotic, or pyroptotic cell death, and its effect on HIV-1 release was suppressed by Imipramine (an antidepressant agent known to inhibit microvesicle formation by interfering with membrane-associated acid sphingomyelinase). Virion release was not triggered by oxidized ATP, whereas the effect of eATP was inhibited by a specific inhibitor of the P2X7 receptor (P2X7R). Thus, eATP triggered the discharge of virions actively accumulating in VCC of infected macrophages via interaction with the P2X7R in the absence of significant cytopathicity. These findings suggest that the microvesicle pathway and P2X7R could represent exploitable targets for interfering with the VCC-associated reservoir of infectious HIV-1 virions in tissue macrophages. 
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Matherials & Methods
CCR5-Dependent (R5) HIV-1 infection of MDM. Human MDM were infected with the macrophage-tropic, laboratory-adapted R5 HIV-1 BaL strain at the multiplicity of infection (moi) of 0.1. Multiple aliquots of culture supernatants were collected every 3 days over a 5-week period and stored at −20°C to assess virus production. At the end of each infection experiment, supernatants were thawed and analyzed for their viral content by measuring the levels of virion-associated RT activity present in the supernatant, with a radioactive assay. Considering that 99% of the RT enzyme is virion-associated, this assay is a faithful indication of the production of new progeny virions (5). Infectivity of VCC-Release HIV-1 Virions. The TZM-bl cell line was generated from CXCR4 + HeLa cells engineered to express CD4 and CCR5 as well, and contains integrated reporter genes for firefly luciferase (luc) and E. Coli β-galactosidase (β-gal) under the control of an HIV-1 LTR, thereby permitting sensitive and accurate measurements of infection. Ultrastructural Analysis. At 15 d.p.i., MDM were stimulated with eaTP for up to 30 min. after stimulation, the cells were washed and scraped with a rubber policeman and analyzed by transmission electron microscopy (TEM). The cells were fixed for 2 h at 4°C with 4% paraformaldehyde and 2.5% glutaraldehyde in 125 mM cacodylate buffer, then postfixed for 1 h with 2% OsO 4 in 125 mM cacodylate buffer, washed and embedded in EPON. Thin sections were collected on uncoated grids, stained with uranil and lead citrate, and examined in a Leo912-Omega transmission electron microscope (Carl Zeiss). 
CONCLUSIONS

